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Introduction
Infertility is the inability of a sexually active, non-
contracepting couple to achieve pregnancy in one
year.1 It is found to be highly prevalent in South Asia,
with an estimated rate of 3% and above cases of
primary infertility in Pakistan.2 Advancement in medical
expertise and technology has made way for effective
treatment modalities of infertility, available for
individuals of suboptimal reproductive health.3 One of
the artificial reproductive techniques (ART) is intra-
cytoplasmic sperm injection (ICSI) in which single
sperm is introduced by a micropipette into the centre of
the egg.4
ICSI is a procedure which is indicated in anatomical and
physiological aberration in the male reproductive tract or
abnormality in sperm count, morphology and motility.
Besides, ICSI has been opted for in cases of failure with
respect to in-vitro fertilisation (IVF) cycles irrespective of
cause of infertility. Among the many factors involved in
female infertility are the hormonal abnormalities,
especially of follicle stimulating hormone (FSH),
luteinizing hormone (LH), progesterone, estradiol,
prolactin and thyroid hormones. Out of these hormones,
FSH and LH have a central role in regulation of delicate
endocrine mechanisms of the ovary.5
FSH and LH belong to the human gonadotropins family;
they stimulate the ovaries and are essential for
reproduction.6 FSH secreted from the anterior pituitary
gland not only stimulates growth of ovarian follicles, but
also promotes estradiol (E2) production. Basal FSH is an
established endocrine marker of ovarian reserve (OR),
along with inhibin B, E2,anti-Mullerian hormone (AMH)
and antral follicle count (AFC).7 FSH initiates follicular
growth and stimulates the ovaries to produce the steroid
hormones, LH surge causes ovulation and regulates the
release of reproductive hormones.8 High FSH levels are
associated with premature ovarian failure.9 So, the right
balance between FSH and LH in women is essential for
reproduction.10
With age, fertility in women decreases. An increase in FSH
occurs before elevation in LH so the first intimation of
decreased OR may be due to an increased FSH-LH
ratio.11,12 Adequate OR is a prerequisite for successful IVF
or ICSI treatment; thus a measurement of FSH/LH ratio is
important to determine which patients have a high
outcome possibility.
The current study was planned to observe the effect of
FSH-LH ratio on oocyte parameters, quality of embryo,
implantation and clinical pregnancy rate after ICSI.
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Abstract
Objective: To observe the effect of follicle stimulating hormone-luteinizing hormone ratio on oocyte parameters,
quality of embryo, implantation and clinical pregnancy rate after intracytoplasmic sperm injection.
Methods: The retrospective study was conducted at a fertility clinic in Islamabad, Pakistan, and comprised data of
primary infertile females who underwent intracytoplasmic sperm injection from June 2011 to March 2013. All
subjects had duration of infertility more than two years, and age range was 20-40 years. Follicle stimulating
hormone and luteinizing hormone were estimated by enzyme-linked immunosorbent assay on day 3 of the cycle
and the ratio was calculated. Groups were stratified on the basis of median ratio into groups I <1.26 and group II
>1.26. SPSS 20 was used for data analysis.
Results: Of the 282 females, 143(51%) were in group I and 139(49%) in group II. Pregnancy was acquired by 79(55%)
and 22(16%) females in group I and II respectively. The number of retrieved, metaphase, fertilised oocytes, cleaved
embryos and endometrial thickness was significantly larger in group I (p< 0.0001).
Conclusion: Follicle stimulating hormone-luteinizing hormone ratio less than 1.26 was associated with good oocyte
parameters, top quality embryo and implantation after intracytoplasmic sperm injection.
Keywords: Infertility, Intracytoplasmic sperm injection, follicle stimulating hormone, luteinizing hormone, FSH/LH
ratio. (JPMA 65: 1330; 2015)
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Subjects and Methods
The retrospective study was conducted at Islamabad
Clinic, Islamabad, and comprised data related to females
who underwent ICSI between June 2011 and March 2013.
After approval from the institutional ethics review board,
women records of women aged 18-40 years, who had
primary infertility for 2 years, whose existent both ovaries
were without any morphological abnormalities, had
normal ovulatory cycle (25-35 days), had body mass index
(BMI ) 18-27 kg/m2, and whose basal FSH levels on day 2
was <10 mI U/mL. Infertile cases with cause in the male
partner were excluded.
FSH and LH levels had been estimated by enzyme-
linked immunosorbent assay (ELISA) on day three of
the cycle and the ratio was calculated. These patients
underwent long down-regulation of the pituitary gland
by use of gonadotrophin releasing hormone (GnRH)
agonist. Development of the follicular cohort was
induced with higher doses of rRecombinantFSH (rFSH)
(Puregon). Follicular growth was monitored by
transvaginal scan (TVS). When the leading follicles were
mature, ovulation was triggered with human chorionic
gonadotropin (hCG; injection Pregnyl). Endometrial
thickness was measured on this day with the help of
TVS. The oocytes were retrieved from the follicles 36
hours after injection by ultrasound-guided
transvaginal aspiration of the follicular fluid.
Microinjected mature oocytes were grown in culture
medium till blastocysts stage. On average 1 to
3blastocysts were transferred into the uterine cavity on
day 5 after retrieval of the oocytes.
A clinical pregnancy (CP) was confirmed by the presence
of one or more gestation sacs with cardiac activity on TVS,
2 weeks after positive pregnancy test by serum beta hCG
measurement.13 Mean implantation rate was the
proportion of embryos transferred resulting in an
intrauterine gestational sac.4,13
The cycle characteristics, oocyte and embryo parameters,
implantation and CP rate were compared in groups
stratified on median level of FSH/LH ratio 1.26. Group I
included women with FSH/LH ratio <1.26 and group II
comprised those with >1.26 FSH/LH ratio.
Data was entered into MS Excel and analysed using SPSS
20. Frequencies and percentages for categorical variables
andmean ± standard deviation were taken for continuous
variables. Shapiro-Wilk test identified non-normal
variables in the data, hence Mann-whitney U test was
used to assess difference between variables on the basis
of median value of FSH/LH ratio. Results were considered
significant at p<0.05.
Results
Of the 282 females whose records were reviewed,
143(51%) and 139(49%) comprised group I and II
respectively. Overall, mean FSH level was 6.68±1.08, mean
LH was 5.19±1.42, and the mean FSH/LH ratio was
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Table: Comparison of cycle characteristics.
Variables Group I Group II P value
FSH/LH ratio FSH/LH ratio
< 1.26 > 1.26
n= 143 n= 139
Age at marriage 24.55 ± 4.36 25.47 ± 4.62 0.08
Cause of Infertility
Polycystic 83(58%) 43 (31%) 0.0001
Tubal 3 (3%) 0
Unexplained 57 (39% 96 (69%) 0.0001
Duration of infertility 7.13± 4.14 7.09 ±3.59 NS
Body mass index (Kg/m2) 24.03 ±3.59 24.47 ± 3.78 NS
Pre ovulatory follicle count 7.98 ±1.91 7.63 ±1.81 0.08
Number of oocytes/patient 7.87 ± 1.70 7.50 ± 1.63 0.0001
Metaphase II 7.65 ± 1.65 6.59 ± 2.10 0.00005
Fertilised oocytes 6.34 ± 1.29 5.54 ± 1.70 0.0001
Number of cleaved embryos 6.24 ± 1.25 5.46 ± 1.65 0.001
Grade 1 2.66 ± 1.64 1.43 ± 1.26 0.001
Grade 2 2.38 ± 1.26 2.75 ± 1.33 0.004
Grade 3 1.20 ± 0.47 1.29 ± 0.51 NS
Blastocysts formed 2.27 ± 0.53 1.93 ± 0.52 0.0001
Number of transferred embryos 1.71 ± 0.57 1.53 ± 0.58 0.007
Endometrial thickness 9.51 ± 3.47 7.65 ± 3.09 0.0001
Implantation rate (%) 49.29 14.23 0.0001
Total number of gestational sacs/
Total number of embryos
transferred × 100
p<0.0001.
Figure: Comparison of FSH/LH ratio with clinical pregnancy. The ratio of median, 25th
and 75th percentiles are shown in box plots for both groups.
FSH: Follicle stimulating hormone
LH: Luteinizing hormone.
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1.40±0.51.
Age, BMI and duration of infertility did not show
significant difference in the groups (Table). The number of
retrieved, mature (metaphase) and fertilised oocytes,
cleaved embryos and endometrial thickness was
significantly larger in group I (p<0.0001). Total number of
pregnancies in the study group was 101/282 with a CP
rate of 36%. In group I, non-pregnant were 64/143 (45%)
and 79/143 (55%) were pregnant. In group II, 117/139
(84%) were non-pregnant and 22/139 (16%) had
conceptions. CP rate in group I was 79/101 (78%) and
22/101 (22%) in group II. The implantation rate in group I
was significantly higher than in group II (p<0.00-1).
The box plots of FSH-LH ratio with respect to non-
pregnant (181) and CP (n=101) groups showed greater
number of CPs in group I (Figure).
Discussion
Several earlier studies have investigated the effects of
FSH-LH ratio on IVF outcomes or ovarian response. This
study was carried out to identify and confirm the
importance of FSH-LH ratio as an indicator of outcomes
after ICSI procedures in Pakistan.Women with LH and FSH
concentrations within the normal limits and those with
low FSH/LH ratio are typically defined as 'normal' and
'high' responders respectively. High responders have
been identified by infertility specialists as females with
high peak E2 and better oocyte recovery and embryo
quality.14
We have observed significantly lower number of oocytes
in group II which exhibited higher FSH/LH ratio. It is
reported that higher levels of FHS/LH ratio greater than 2
is associated with lower number of retrieved oocytes.15
Similar results were presented by other researchers who
observed a decreased oocyte retrieval in patients with a
high FSH/LH ratio (< or = 2).16
The number of oocytes in metaphase II indicates the
number of oocytes that reach maturation and is thus a
sign of positive outcome of ICSI. We observed that
number of oocytes in metaphase II were significantly
lower in group II. In a study on mature oocyte yield in
pituitary down-regulated women, it was observed that
the number of mature oocytes was inversely related to
the FSH/LH ratio.17 A similar study on patients undergoing
IVF cycles showed that elevated FSH-LH ratio was
associated with fewer mature oocytes.18 On the contrary,
a study showed no significant difference in the number of
mature oocytes in groups demarcated by 3 FSH-LH
ratio.19 The results may also be different due to a large
difference between the two group sizes, 477 and 198
respectively, and difference in median value of both
research studies.
The results of our study also showed a significant
difference between FSH-LH ratio and the number of
cleaved and grading of embryos. The results are similar to
the findings of a previous study which showed an inverse
relation between FSH-LH ratio and the number of day 3
embryos.20 Our study size was almost similar to theirs,
with the difference of a higher FSH-LH ratio in their study
females. Literature search did not reveal many other
studies to highlight relation between cleaved embryos
and FSH-LH levels.
The number of blastocysts formed were also significantly
different in the two groups, with more blastocysts formed
in group I. In a similar study, there was no significant
difference observed in the number of frozen blastocyst
between the two groups stratified on the basis of FSH-LH
ratio 3.19 Implantation of embryo depends on their quality
and endometrial receptivity usually estimated by
measurement of endometrial thickness.21,22 Females with
low FSH/LH ratio had thick endometrial lining required for
implantation of embryo. Similar findings were reported in
a study that showed a significantly decreased
endometrial thickness with 3 FSH-LH ratio.23 The
implantation rates in group I was high which is supported
by researchers who observed aspiration of fewer mature
oocytes and poorer implantation rates in those
undergoing IVF treatment.24 On the contrary, a study
showed no significance difference on the implantation
rate between the two groups, FSH/LH > or =2 and FSH/LH
<2.25 This difference may be due to the lower sample size,
or because the women included all had polycystic ovary
syndrome (PCOS).
Our study had limitations as it was a uni-centre study
which involved non-randomised sampling technique
with unequal proportion of cases. Receiver operating
curve (ROC) was not used in this study to determine the
cutoff values of FSH-LH ratio for demarcation of the
groups.
We recommend that hormone assays, including FSH and
LH levels, should be a prerequisite before starting ART
cycles. FSH-LH ratio could be considered as a standard
screening test to categorise patients who can best benefit
from ART treatment. If maximum accuracy in counselling
is warranted, endocrine testing, especially of FSH and LH,
may be used for predictive information along with other
parameters such as AFC and AMH.
Conclusion
Patients with an elevated FSH/LH ratio (>1.26) had
decreased number of oocytes, mature oocytes, cleaved
embryos, endometrial thickness, implantation rate and
blastocysts formed; all implying poor response to ICSI.
FSH-LH ratio can be used to assess response of treatment
in ART.
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